Disciplina Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.81K Hold
4
﹤0.01% 66
2026
Q1
$3.69K Buy
+4
New +$4.05K ﹤0.01% 67
2025
Q1
Sell
-10
Closed -$7.51K 71
2024
Q4
$7.51K Hold
10
﹤0.01% 62
2024
Q3
$8.6K Sell
10
-678
-99% -$610K ﹤0.01% 60
2024
Q2
$139K Buy
688
+416
+153% +$333K 0.02% 32
2024
Q1
$212K Hold
272
0.04% 22
2023
Q4
$159K Buy
272
+1
+0.4% +$584 0.03% 23
2023
Q3
$146K Hold
271
0.03% 23
2023
Q2
$127K Buy
271
+124
+84% +$52K 0.02% 26
2023
Q1
$50.3K Sell
147
-17
-10% -$5.73K 0.01% 27
2022
Q4
$60K Hold
164
0.02% 27
2022
Q3
$52.9K Sell
164
-32
-16% -$10.1K 0.01% 23
2022
Q2
$63.6K Buy
196
+1
+0.5% +$300 0.01% 23
2022
Q1
$55.9K Sell
195
-23
-11% -$5.92K 0.01% 23
2021
Q4
$60.1K Buy
218
+27
+14% +$6.84K 0.01% 23
2021
Q3
$44.1K Buy
191
+8
+4% +$1.97K 0.01% 32
2021
Q2
$42.1K Buy
183
+27
+17% +$5.42K 0.01% 29
2021
Q1
$29.1K Buy
156
+55
+54% +$10.8K 0.01% 34
2020
Q4
$17.1K Buy
+101
New +$15.1K 0.01% 33

Other funds holding LLY

Disciplina Capital Management's LLY Position: Q2 2026 in Review

Disciplina Capital Management held its Eli Lilly (LLY) position steady in Q2 2026 at 4 shares worth $4.81K. The position accounts for ﹤0.01% of the portfolio, ranked #66.

Disciplina Capital Management first reported a position in LLY in Q4 2020 and has held it in 19 quarters since. The position peaked at $212K in Q1 2024. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Disciplina Capital Management held 4 shares of Eli Lilly worth $4.81K as of Q2 2026.
  • Disciplina Capital Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up ﹤0.01% of Disciplina Capital Management's portfolio in Q2 2026, its #66 holding.
  • Disciplina Capital Management first reported a position in Eli Lilly in Q4 2020 and has held it in 19 quarters since.
  • Disciplina Capital Management's Eli Lilly position peaked at $212K in Q1 2024.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Disciplina Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.